Skip to Content

Hydromer Inc HYDI

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Hydromer Inc is a polymer research and development company. The company is engaged in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer-based products and services. Its segment includes Industrial and Medical. The company generates maximum revenue from Medical segment. It serves the medical device, pharmaceutical, animal health, biotechnology, industrial, cosmetic and personal care and other markets. Geographically, it derives a majority of revenue from the United States.

4715 Corporate Drive NW, Suite 200
Concord, NC, 28027
T +1 800 208-0314
Sector Basic Materials
Industry Specialty Chemicals
Most Recent Earnings Mar 31, 2019
Fiscal Year End Jun 30, 2020
Stock Type Cyclical
Employees 36